Halyard Health (NYSE:HYH) is scheduled to be posting its quarterly earnings results before the market opens on Monday, February 26th. Analysts expect Halyard Health to post earnings of $0.50 per share for the quarter.
Halyard Health (NYSE HYH) opened at $47.91 on Friday. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49. Halyard Health has a 1-year low of $35.24 and a 1-year high of $50.99. The company has a market capitalization of $2,215.83, a price-to-earnings ratio of 40.26, a price-to-earnings-growth ratio of 2.48 and a beta of 1.71.
A number of research analysts have commented on the company. Zacks Investment Research lowered Halyard Health from a “buy” rating to a “hold” rating in a report on Thursday, February 1st. TheStreet raised Halyard Health from a “c+” rating to a “b” rating in a report on Monday, December 4th. ValuEngine raised Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, November 4th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $52.00 price objective on shares of Halyard Health in a report on Friday, November 3rd. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Halyard Health currently has a consensus rating of “Buy” and a consensus price target of $49.00.
Halyard Health Company Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.